Quarterly Research Grant Funding Programme
We fund internationally and accept applications from academics and commercial entities. However, the costs in commercial applications should be justified and equivalent to academic costs where possible. * Requirements of commercial entity
2025/2026 application deadlines:
- November 3rd 2025
- January 12th 2026
- April 13th 2026
- October 12th 2026
Combination therapies funding call
Open call from Wednesday 1 October until Monday 24 November. * Requirements of commercial entity
Q&A Sessions
As this is a new funding call, we will be hosting two question and answer (Q&A) sessions via Zoom to give prospective applicants an overview of the different types of combinations, an update from a workshop hosted earlier this year and to answer any questions applicants might have.
These sessions will be held on:
• Thursday 16 October 2025, 10am (BST)
• Monday 3 November 2025, 4pm (GMT)
iLCT Pipeline Research Acceleration Programme
Cure Parkinson’s has set up this funding call with the objective of accelerating additional research required for therapeutic candidates evaluated by the iLCT committee that were not considered ready to move forward into clinical trials in people with Parkinson’s. The type of research covered by this programme may include preclinical, epidemiological, dose-finding, or target engagement research.
Max project duration (typically 6 -18 months)
Next call – early next year
